Lv3
230 积分 2024-01-08 加入
Multispecific T-cell engagers attract cancer drug developers
8小时前
待确认
Trends in the landscape of clinical trials of innovative drugs in China since 2015
1个月前
已完结
Unlocking the potential of T cell engagers in solid tumors
2个月前
已完结
Innovative antibody therapeutic development in China compared with the USA and Europe
3个月前
已完结
我国成人疫苗接种指导建议
3个月前
已完结
HER3 upregulation reduces DS-8201 sensitivity in HER2-positive tumor cells by ATR/CHK1/FoxO1 signaling cascade
4个月前
已完结
Non-specificity as the sticky problem in therapeutic antibody development
6个月前
已完结
CD56 on immune and tumor cells: what is the known and beyond?
7个月前
已关闭
Albumin and its application in drug delivery
7个月前
已完结
Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
8个月前
已完结
皖公网安备34019202002308
